CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹4,155 Cr | ₹2,835 Cr | ₹2,559 Cr | ₹2,401 Cr | ₹1,547 Cr |
What is the latest Profit After Tax of CIPLA ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹4,155 Cr |
| Mar2024 | ₹2,835 Cr |
| Mar2023 | ₹2,559 Cr |
| Mar2022 | ₹2,401 Cr |
| Mar2021 | ₹1,547 Cr |
How is Profit After Tax of CIPLA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,155 Cr | 46.55 | |
| Mar2024 | ₹2,835 Cr | 10.78 | |
| Mar2023 | ₹2,559 Cr | 6.59 | |
| Mar2022 | ₹2,401 Cr | 55.23 | |
| Mar2021 | ₹1,547 Cr | - | |
Compare Profit After Tax of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹99,088.8 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| MANKIND PHARMA | ₹87,624.9 Cr | 3.9% | -5.4% | -12.6% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.9% |
-7.8% |
-12.5% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses